Centanni S - Search Results

1

Cazzola M, Centanni S, Donner CF. Cazzola M, et al. Among authors: centanni s. Pulm Pharmacol Ther. 1998;11(5-6):381-392. doi: 10.1006/pupt.1999.0174. Pulm Pharmacol Ther. 1998. PMID: 10208827 No abstract available.

2

Anticholinergic agents.

Cazzola M, Centanni S, Donner CF. Cazzola M, et al. Among authors: centanni s. Pulm Pharmacol Ther. 1998 Oct-Dec;11(5-6):381-92. Pulm Pharmacol Ther. 1998. PMID: 10210656 Review. No abstract available.

3

Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.

Cazzola M, Vinciguerra A, Di Perna F, Califano C, Calderaro F, Salzillo A, Centanni S. Cazzola M, et al. Among authors: centanni s. J Chemother. 1999 Apr;11(2):119-25. doi: 10.1179/joc.1999.11.2.119. J Chemother. 1999. PMID: 10326742 Clinical Trial.

4

Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.

Cazzola M, Di Perna F, Centanni S, Califano C, Donner CF, D'Amato M, D'Amato G. Cazzola M, et al. Among authors: centanni s. Thorax. 1999 Dec;54(12):1083-6. doi: 10.1136/thx.54.12.1083. Thorax. 1999. PMID: 10567627 Free PMC article. Clinical Trial.

5

Non-pulmonary effects induced by the addition of formoterol to budesonide therapy in patients with mild or moderate persistent asthma.

Centanni S, Carlucci P, Santus P, Boveri B, Tarricone D, Fiorentini C, Lombardi F, Cazzola M. Centanni S, et al. Respiration. 2000;67(1):60-4. doi: 10.1159/000029464. Respiration. 2000. PMID: 10705264

6

Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.

Cazzola M, Di Perna F, Boveri B, Di Marco F, Diamare F, Centanni S. Cazzola M, et al. Among authors: centanni s. J Chemother. 2000 Jun;12(3):216-22. doi: 10.1179/joc.2000.12.3.216. J Chemother. 2000. PMID: 10877516 Clinical Trial.

7

Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.

Cazzola M, Boveri B, Carlucci P, Santus P, DiMarco F, Centanni S, Allegra L. Cazzola M, et al. Among authors: centanni s. Pulm Pharmacol Ther. 2000;13(6):301-5. doi: 10.1006/pupt.2000.0258. Pulm Pharmacol Ther. 2000. PMID: 11061985 Clinical Trial.

8

Additive effects of salmeterol and fluticasone or theophylline in COPD.

Cazzola M, Di Lorenzo G, Di Perna F, Calderaro F, Testi R, Centanni S. Cazzola M, et al. Among authors: centanni s. Chest. 2000 Dec;118(6):1576-81. doi: 10.1378/chest.118.6.1576. Chest. 2000. PMID: 11115442 Clinical Trial.

9

Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD.

Cazzola M, Centanni S, Regorda C, di Marco F, di Perna F, Carlucci P, Boveri B, Santus P. Cazzola M, et al. Among authors: centanni s. Pulm Pharmacol Ther. 2001;14(1):41-5. doi: 10.1006/pupt.2000.0267. Pulm Pharmacol Ther. 2001. PMID: 11162418 Clinical Trial.

10

Advances in the research and development of chemotherapeutic agents for respiratory tract bacterial infections.

Cazzola M, Blasi F, Centanni S, Donner CF, Allegra L. Cazzola M, et al. Among authors: centanni s. Pulm Pharmacol Ther. 2001;14(5):367-81. doi: 10.1006/pupt.2001.0302. Pulm Pharmacol Ther. 2001. PMID: 11603950 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters